More from less
How Shire’s value could increase after spinning out its ADHD business
Shire plc (LSE:SHP; NASDAQ:SHPG) could increase in value while decreasing in size, but the market isn’t convinced.
Fourteen months after closing its acquisition of rare disease company Baxalta Inc., Shire is considering a flotation of its neuroscience business as part of an ongoing companywide strategic review.
On its 2Q17 earnings call,